Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh
In this episode of the Talking Biotech podcast, Dr. Kevin Folta speaks with Dr. Neela Patel and Dr. Diane Hollenbaugh from Bonum Therapeutics about the emerging field of conditionally active biologics. They discuss the challenges of current therapies, the innovative mechanisms behind their drug development, and the potential of immuno-oncology to revolutionize cancer treatment. The conversation also covers the market landscape, the origin story of Bonum, and the future directions for their pipeline, emphasizing the importance of targeted therapies in improving patient outcomes.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Talking Biotech with Dr. Kevin Folta
New Technology in Severe Burn Care - Dr. Katie Bush
New Methods in Early Cancer Detection - Dr. Nate Montgomery
Strategies in Combating Chronic Kidney Disease - Dr. Salvadore Viscomi
AI and the Future of Healthcare -- Dr. Emilia Javorsky
Get summaries like this every morning.
Free AI-powered recaps of Talking Biotech with Dr. Kevin Folta and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.